These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16611940)

  • 41. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors.
    Cáceres JF; Stamm S; Helfman DM; Krainer AR
    Science; 1994 Sep; 265(5179):1706-9. PubMed ID: 8085156
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation.
    Petersen-Mahrt SK; Estmer C; Ohrmalm C; Matthews DA; Russell WC; Akusjärvi G
    EMBO J; 1999 Feb; 18(4):1014-24. PubMed ID: 10022843
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing.
    Powell DM; Amaral MC; Wu JY; Maniatis T; Greene WC
    Proc Natl Acad Sci U S A; 1997 Feb; 94(3):973-8. PubMed ID: 9023367
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exonic splicing enhancer motif recognized by human SC35 under splicing conditions.
    Liu HX; Chew SL; Cartegni L; Zhang MQ; Krainer AR
    Mol Cell Biol; 2000 Feb; 20(3):1063-71. PubMed ID: 10629063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1.
    Cartegni L; Krainer AR
    Nat Genet; 2002 Apr; 30(4):377-84. PubMed ID: 11925564
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-throughput analysis revealed mutations' diverging effects on
    Souček P; Réblová K; Kramárek M; Radová L; Grymová T; Hujová P; Kováčová T; Lexa M; Grodecká L; Freiberger T
    RNA Biol; 2019 Oct; 16(10):1364-1376. PubMed ID: 31213135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Missense or splicing mutation? The case of a fibrinogen Bbeta-chain mutation causing severe hypofibrinogenemia.
    Asselta R; Duga S; Spena S; Peyvandi F; Castaman G; Malcovati M; Mannucci PM; Tenchini ML
    Blood; 2004 Apr; 103(8):3051-4. PubMed ID: 15070683
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overexpression of essential splicing factor ASF/SF2 blocks the temporal shift in adenovirus pre-mRNA splicing and reduces virus progeny formation.
    Molin M; Akusjärvi G
    J Virol; 2000 Oct; 74(19):9002-9. PubMed ID: 10982344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Control of 3' splice site choice in vivo by ASF/SF2 and hnRNP A1.
    Bai Y; Lee D; Yu T; Chasin LA
    Nucleic Acids Res; 1999 Feb; 27(4):1126-34. PubMed ID: 9927747
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5' or 3' splice site activation.
    Bourgeois CF; Popielarz M; Hildwein G; Stevenin J
    Mol Cell Biol; 1999 Nov; 19(11):7347-56. PubMed ID: 10523623
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of multiple cryptic donor splice sites by the common congenital afibrinogenemia mutation, FGA IVS4 + 1 G-->T.
    Attanasio C; de Moerloose P; Antonarakis SE; Morris MA; Neerman-Arbez M
    Blood; 2001 Mar; 97(6):1879-81. PubMed ID: 11238133
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence for the function of an exonic splicing enhancer after the first catalytic step of pre-mRNA splicing.
    Chew SL; Liu HX; Mayeda A; Krainer AR
    Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10655-60. PubMed ID: 10485881
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides.
    Balestra D; Barbon E; Scalet D; Cavallari N; Perrone D; Zanibellato S; Bernardi F; Pinotti M
    Hum Mol Genet; 2015 Sep; 24(17):4809-16. PubMed ID: 26063760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Growth hormone deficiency and splicing fidelity: two serine/arginine-rich proteins, ASF/SF2 and SC35, act antagonistically.
    Solis AS; Peng R; Crawford JB; Phillips JA; Patton JG
    J Biol Chem; 2008 Aug; 283(35):23619-26. PubMed ID: 18586677
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A splicing-independent function of SF2/ASF in microRNA processing.
    Wu H; Sun S; Tu K; Gao Y; Xie B; Krainer AR; Zhu J
    Mol Cell; 2010 Apr; 38(1):67-77. PubMed ID: 20385090
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Splicing of phenylalanine hydroxylase (PAH) exon 11 is vulnerable: molecular pathology of mutations in PAH exon 11.
    Heintz C; Dobrowolski SF; Andersen HS; Demirkol M; Blau N; Andresen BS
    Mol Genet Metab; 2012 Aug; 106(4):403-11. PubMed ID: 22698810
    [TBL] [Abstract][Full Text] [Related]  

  • 57. hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing.
    Kashima T; Rao N; David CJ; Manley JL
    Hum Mol Genet; 2007 Dec; 16(24):3149-59. PubMed ID: 17884807
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An erythroid differentiation-specific splicing switch in protein 4.1R mediated by the interaction of SF2/ASF with an exonic splicing enhancer.
    Yang G; Huang SC; Wu JY; Benz EJ
    Blood; 2005 Mar; 105(5):2146-53. PubMed ID: 15522963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Drosophila RNA-binding protein RBP1 is localized to transcriptionally active sites of chromosomes and shows a functional similarity to human splicing factor ASF/SF2.
    Kim YJ; Zuo P; Manley JL; Baker BS
    Genes Dev; 1992 Dec; 6(12B):2569-79. PubMed ID: 1340470
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiple activities of the human splicing factor ASF.
    Harper JE; Manley JL
    Gene Expr; 1992; 2(1):19-29. PubMed ID: 1535526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.